vTv Therapeutics Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $36.8M | $0 | $0 | $0 | $0 | $0 | $1.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $8.8M | $9.0M | $7.0M | $4.1M | $2.8M | $3.2M | $3.4M | $2.6M |
| SG&A Expense | $5.2M | $4.6M | $3.7M | $3.6M | $3.7M | $3.3M | $3.7M | $4.0M |
| Operating Income | $-13.9M | $23.3M | $-10.7M | $-7.7M | $-6.5M | $-6.5M | $-7.2M | $-5.6M |
| Operating Margin | — | 63.1% | — | — | — | — | — | -562.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-13.1M | $24.1M | $-10.3M | $-7.4M | $-6.2M | $-5.8M | $-6.4M | $-5.9M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $100.0K |
| Net Income | $-13.1M | $24.1M | $-8.7M | $-6.0M | $-5.1M | $-4.8M | $-5.2M | $-4.9M |
| Net Margin | — | 65.5% | — | — | — | — | — | -486.5% |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |